top of page
CVCT London.png

23rd Global CVCT Forum

logo v3.png
CVCT 2023 multistakeholders

CROs-AROs

Academics

Principal Investigators

Patients-

Advocacy

Regulatory

(FDA, EMA)

Industry R&D

Clinicians

Lawyers

Major journal editors

Statisticians-Methodologists

Payers-HTAs

MedTech-BioTech

Investors

CVCT Chairpersons

courbes_edited_edited_edited.jpg
20250422_110127.jpeg

Faiez Zannad

Founder & chairman

UNIVERSITE DE LORRAINE, NANCY, FRA

  • Twitter
  • LinkedIn

Bertram Pitt

Co-chairman

UNIVERSITY OF MICHIGAN, ANN ARBOR, USA

  • LinkedIn
courbes_edited_edited_edited.jpg
Bertram Pitt, CVCT
courbes_edited_edited_edited.jpg
Butler_photo.jpg

Javed Butler

University of Mississippi Med Center

Jackson, Mississppi, United States

  • Twitter
  • LinkedIn

Co-chairman

LATE-BREAKING CLINICAL TRIAL SUBMISSIONS TO CVCT 2026

A New Opportunity to Present Groundbreaking Research!

The CVCT Meeting is excited to announce a new feature this year: an invitation for Late-Breaking Clinical Trial Submissions! This is your chance to present impactful, cutting-edge clinical trial results at our prestigious meeting.

​

DISCOVER HERE

growth.png

Controlled growth

THE GLOBAL CVCT FORUM HAS GROWN STEADILY AND SLOWLY, WITH CONTROLLED GROWTH AS TO STAND TO ITS REPUTATION OF A “BOUTIQUE MEETING”.

CLINICAL TRIAL SCIENCE
AT ITS BEST

NO promotion,

NO exhibition,

NO marketing,

NO lecturing !

EXPAND OVER
INCLUDING
INVOLVING

03

45+

450+

DAYS
SESSIONS
SPEAKERS
bottom of page